HYDERABAD, India--(BUSINESS WIRE)--Ocimum Biosolutions announced the launch of a microarray-based test (research use only) for the latest version of the H1N1 flu. The company reported that it updated its custom chip probes using sequence information from the latest strain of the swine flu from the NCBI site. Most of these sequences have been submitted worldwide in the past 96 hours. The CDC and US Food and Drug Administration have authorized the emergency use of an RT-PCR based molecular diagnostic assay to identify cases of swine flu in the current outbreak in the US.
